The Breast Cancer Research Foundation

In just the last decade, 18 new breast cancer treatments have been FDA-approved thanks to clinical findings from BCRF investigators and others. Every breakthrough brings us closer to better outcomes, more options, and a future without breast cancer. This is the power of research. Explore the full timeline of research breakthroughs here: https://lnkd.in/eMkuWKGy

Breast cancer is the most common cancer among Asian American, Native Hawaiian, and Pacific Islander (AAPI) women—and rates are rising fast, especially among those under 50. Join us TOMORROW on Friday, October 24, at 12 PM ET for a free BCRF webinar, “AAPI Women at Risk: The Breast Cancer Trend We Can’t Ignore.” Featuring BCRF investigators Drs. Neil Iyengar and Scarlett Gomez, alongside actress, producer, author and breast cancer thriver Sheetal Sheth, and moderated by BCRF's Sadia Haque Zapp, this conversation will explore what’s driving rising rates, how risks differ across AAPI backgrounds, and what you can do to stay informed and empowered. We’ll also discuss the importance of early screening, dense breast awareness, and breaking cultural barriers to care. Sign up for free here: https://bit.ly/4o5WR0D

Taylor Orlandoni is running the 2025 New York City Marathon with #TeamBCRF in support of her mom and all the other women in her life who have been diagnosed with breast cancer. "I feel lucky to enjoy life alongside the survivors I know, and I thank breast cancer research for its part in their being here," she said. Help us thank Taylor in the comments. If you want to support her fundraising, you can do so here: https://bit.ly/3KWIvRz

A major milestone for early detection: The FDA has authorized Clairity Breast, an AI-powered tool that uses screening mammograms to predict a woman’s five-year risk of developing breast cancer. Developed by BCRF investigator Dr. Connie Lehman and her team, this groundbreaking innovation—partly funded by BCRF—has the potential to make breast cancer risk assessment more personalized, accessible, and equitable for women everywhere. Learn more about this important advancement in TODAY Show's recent feature: https://lnkd.in/en_RKA3w

For Shep and Ian Murray, co-founders of vineyard vines, the mission to end breast cancer is deeply personal. Inspired by their mom’s strength and resilience, they’re committed to supporting lifesaving research and giving back to the community. Through December 31, vineyard vines will donate 10 percent of the purchase price from the Breast Cancer Awareness Collection to BCRF, with a guaranteed minimum contribution of $40,000 to fuel the world’s most promising breast cancer research. Read more about vineyard vines’ commitment: https://lnkd.in/eJP3jFRk

Metastatic breast cancer (MBC) is more than a medical term, it’s a lived experience that impacts countless individuals and families every day. At BCRF, we’re funding the world’s most promising research to improve outcomes for those living with MBC. We’re proud to support the Metastatic Breast Cancer Alliance's “This Is MBC” campaign, which shines a light on the people behind the disease— stories and facts from those who know it firsthand. Learn more about the campaign and how you can get involved here: https://lnkd.in/eQJVNtZC

At our Grand Central pop-up earlier this month, hundreds of people shared messages of hope, gratitude, and love, each one written in support of lifesaving breast cancer research. 💌 Today, we’re spotlighting a few of the inspiring postcards written by those who filled out the “This Postcard Can Save Lives” reminder checklist and sent a message to someone they care about. Stay tuned as we continue to share more heartfelt words from our community—each one a powerful reminder of why research matters. Send your own digital postcard today here: https://lnkd.in/ebfTaEPX

Black women are nearly 40% more likely to die from breast cancer than white women. This is more than a statistic, it’s a devastating reality shaped by inequities in access to care, early detection, and treatment. As Toks Olagundoye shares, representation in research matters. Equity in funding matters. Listening to and investing in communities most affected matters. Learn more about breast cancer disparities and how BCRF investigators are actively working to close gaps in outcomes: https://bit.ly/4qn3uNg

"Research has improved the outcomes for so many, and further research can make it even better."—Richard Loud Richard, a male breast cancer thriver, is running the 2025 New York City Marathon with #TeamBCRF to honor his own journey and all of those impacted by the disease. "On a very personal level, it's rare that men are included in breast cancer research and, as a man, supporting any research that can improve the outcomes for men is important to me," he said. "On a broader level, I know more people with breast cancer (mostly women) than with any other type." Help us thank Richard in the comments. If you want to support his fundraising, you can do so here: https://bit.ly/471d5SA